BioCC welcomes Lotos Pharma SIA as a partner in exporting to South-East Asian markets
As part of the Interreg Est-Lat Bio4ASIA project Lotos Pharma SIA visited BioCC to strengthen cooperation and coordinate the future action plan. Despite the impending COVID-19 threat the project team took time to visit BioCC-s fermentation and microbiology lab with a goal of finding a formula for a dietary stimulant suitable for the South East-Asian market. The product is expected to reach a prototype status by the end of 2020.
This article reflects the views of the author. The managing authority of the programme is not liable for how this information may be used.
What is EstLat Bio4Asia?
Bio4ASIA is a cooperation project between two similar companies working in the same industry – producing of food supplements – and based on similar needs and ambitions: to expand and diverse market of their products in order to develop companies and make them competitive in long terms. However, both companies are having different competences and strenghts in different areas of producing and distribution. BioCC OÜ is focused on work with high qualitative lactic acid bacteria cultures and LotosPharma SIA is producing wide assortment of dry forms of medicine and food supplement.